A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies
- PMID: 21341261
- DOI: 10.1002/eji.201041313
A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies
Abstract
A20/TNFAIP3 is an ubiquitin-editing enzyme, important for the regulation of the NF-κB pathway. Mutations in the TNFAIP3 gene have been linked to different human autoimmune disorders. In human B-cell lymphomas, the inactivation of A20 results in constitutive NF-κB activation. Recent studies demonstrate that in mice the germline inactivation of A20 leads to early lethality, due to inflammation in multiple organs of the body. In this report, we describe a new mouse strain allowing for the tissue-specific deletion of A20. We show that B-cell-specific deletion of A20 results in a dramatic reduction in marginal zone B cells. Furthermore, A20-deficient B cells display a hyperactive phenotype represented by enhanced proliferation upon activation. Finally, these mice develop higher levels of serum immunoglobulins, resulting in an excessive production of self-reactive autoantibodies.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice.Blood. 2011 Feb 17;117(7):2227-36. doi: 10.1182/blood-2010-09-306019. Epub 2010 Nov 18. Blood. 2011. PMID: 21088135
-
The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity.Immunity. 2010 Aug 27;33(2):181-91. doi: 10.1016/j.immuni.2010.07.017. Epub 2010 Aug 12. Immunity. 2010. PMID: 20705491 Free PMC article.
-
A20 and CYLD do not share significant overlapping functions during B cell development and activation.J Immunol. 2012 Nov 1;189(9):4437-43. doi: 10.4049/jimmunol.1200396. Epub 2012 Sep 21. J Immunol. 2012. PMID: 23002441
-
A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.Front Immunol. 2018 Feb 21;9:104. doi: 10.3389/fimmu.2018.00104. eCollection 2018. Front Immunol. 2018. PMID: 29515565 Free PMC article. Review.
-
The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.Trends Immunol. 2009 Aug;30(8):383-91. doi: 10.1016/j.it.2009.05.007. Epub 2009 Jul 28. Trends Immunol. 2009. PMID: 19643665 Review.
Cited by
-
Signaling mechanisms regulating B-lymphocyte activation and tolerance.J Mol Med (Berl). 2015 Feb;93(2):143-58. doi: 10.1007/s00109-015-1252-8. Epub 2015 Jan 29. J Mol Med (Berl). 2015. PMID: 25627575 Review.
-
Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.Nat Rev Nephrol. 2015 Jun;11(6):329-41. doi: 10.1038/nrneph.2015.33. Epub 2015 Mar 31. Nat Rev Nephrol. 2015. PMID: 25825084 Review.
-
A20 in Kidney Transplantation and Autoimmunity.Int J Mol Sci. 2024 Jun 16;25(12):6628. doi: 10.3390/ijms25126628. Int J Mol Sci. 2024. PMID: 38928333 Free PMC article. Review.
-
Roles of A20 in autoimmune diseases.Immunol Res. 2016 Apr;64(2):337-44. doi: 10.1007/s12026-015-8677-6. Immunol Res. 2016. PMID: 26135958 Review.
-
Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk.Arthritis Res Ther. 2020 Apr 25;22(1):93. doi: 10.1186/s13075-020-02181-4. Arthritis Res Ther. 2020. PMID: 32334614 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases